Skip to main content
Clinical Trials/NCT00606242
NCT00606242
Completed
Phase 4

A Randomized Double Blind Study of the Dose Response Effects of Fluticasone Propionate on Hypertonic-saline Induced Bronchoconstriction in Asthmatic Subjects

University of California, San Francisco1 site in 1 country44 target enrollmentJanuary 2000
ConditionsAsthma
InterventionsFluticasone

Overview

Phase
Phase 4
Intervention
Fluticasone
Conditions
Asthma
Sponsor
University of California, San Francisco
Enrollment
44
Locations
1
Primary Endpoint
FEV1
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

This study investigates the effect of a inhaled corticosteroid (fluticasone or "Flovent") on airway narrowing induced by hypertonic saline (salty water). The study hypothesis is that fluticasone will be more effective in preventing saline-induced airway narrowing than methacholine-induced narrowing.

Registry
clinicaltrials.gov
Start Date
January 2000
End Date
December 2007
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of asthma

Exclusion Criteria

  • Habitual cigarette smoking

Arms & Interventions

Low dose steroid

Fluticasone, 100 mcg per day

Intervention: Fluticasone

High dose steroid

Fluticasone, 1000 mcg per day

Intervention: Fluticasone

Outcomes

Primary Outcomes

FEV1

Time Frame: Measured every 2 weeks

Secondary Outcomes

  • PC20 methacholine(Measured every 2 weeks)

Study Sites (1)

Loading locations...

Similar Trials